About BakoDx
BakoDx was established in 2007 as a standalone pathology laboratory in Alpharetta, United States. Diagnostic testing and analysis services are offered to support clinical pathology needs in the healthcare sector. Operations are conducted independently, with a focus on specialized laboratory procedures for medical professionals. Key leadership roles are held by executives such as the Founder and Chief Medical Officer, CEO, and Executive Chairman, ensuring oversight of core functions.
- Headquarter Alpharetta, United States
- Founders Wayne L Bakotic
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bako Diagnostics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Fulgent Genetics
& 1 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of BakoDx
Unlock access to complete
Funding Insights of BakoDx
Detailed funding history for BakoDx
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in BakoDx
BakoDx has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Fulgent Genetics and Consonance Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for BakoDx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BakoDx
Investment portfolio details for BakoDx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BakoDx
Detailed financials for BakoDx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bakodx Comparisons
Peer comparison for BakoDx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BakoDx
Detailed competitors of BakoDx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bakodx
Complete news archive for BakoDx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BakoDx
BakoDx was founded in 2007.
BakoDx is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
Laurence R McCarthy is the current CEO of BakoDx.
BakoDx was established in 2007 as a standalone pathology laboratory in Alpharetta, United States. Diagnostic testing and analysis services are offered to support clinical pathology needs in the healthcare sector. Operations are conducted independently, with a focus on specialized laboratory procedures for medical professionals. Key leadership roles are held by executives such as the Founder and Chief Medical Officer, CEO, and Executive Chairman, ensuring oversight of core functions.
BakoDx has 2 investors. Key investors include Fulgent Genetics, and Consonance Capital Partners.